India gets first nasal Covid vaccine: How it can be the 'game changer'

Thursday, 26 January 2023
Centre on Thursday launched India's first nasal Covid-19 vaccine iNCOVACC. Bharat Biotech's Incovacc received government approval for use as a booster dose in the country-wide mass inouclation program. iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion-stabilized SARS-CoV-2 spike protein.

👓 View full article

0 shares	Share Tweet Save Post Send

Video Credit: Wibbitz Top Stories - Published on January 23, 2023

News video: FDA Proposes Annual COVID Vaccination Plan

FDA Proposes Annual COVID Vaccination Plan 01:31

FDA Proposes , Annual COVID Vaccination Plan. ABC reports that health officials in the United States want to make COVID-19 vaccinations more like the annual flu shot. On January 23, the Food and Drug Administration proposed a new vaccination effort that would allow most adults and children to...

💡 newsR Knowledge: Other News Mentions

iNCOVACC Vaccine candidate against COVID-19

Health Minister launches India’s first nasal COVID-19 vaccine ‘iNCOVACC’ | Oneindia News [Video]

Health Minister launches India’s first nasal COVID-19 vaccine ‘iNCOVACC’ | Oneindia News

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first nasal COVID-19 vaccine - 'iNCOVACC' on Thursday. The nasal COVID-19 vaccine has been made by Bharat Biotech. A primary two-dose schedule and a heterologous booster dosage for 'iNCOVACC' have been approved. #iNCOVACC #NasalCovidVaccine #BharatBiotech

Credit: Oneindia Duration: 01:58Published on January 1, 1970

COVID-19 Contagious disease caused by SARS-CoV-2

Vaccination halves risk of long Covid, study shows

Being vaccinated against the SARS-CoV-2 virus halves people's risk of developing long Covid, according to the largest study of its kind. The research, published..
IndiaTimes 2 hours ago

Active Covid cases in country rise to 7,927

India logged 1,249 new coronavirus cases, while the active cases have increased to 7,927, according to the Union health ministry data updated on Friday. The..
IndiaTimes 8 hours ago

World Bank president nominee Ajay Banga tests positive for Covid-19 in Delhi

IndiaTimes 9 hours ago

Amid rising cases, health ministry says no increase in rate of hospitalisation or death due to Covid

Amid a gradual rise in daily Covid-19 cases, the Union Health Ministry said on Thursday that the XBB.1.16 subvariant of Omicron might be the dominant virus..
IndiaTimes 22 hours ago

Amid Covid-19 rise, 349 samples of infectious new variant XBB1.16 found in India

A total of 349 samples of Covid-19's XBB.1.16 variant, which might have been behind the recent rise of coronavirus cases in the country, have been detected,..
IndiaTimes 1 day ago

Bharat Biotech Indian multinational biotechnology company and vaccine manufacturer

SARS Disease caused by severe acute respiratory syndrome coronavirus

Related videos from verified sources

Covid-19: India sees single-day rise of over 500 cases for first time in 114 days | Oneindia News [Video]

Covid-19: India sees single-day rise of over 500 cases for first time in 114 days | Oneindia News

Daily Covid cases cross 500 for the first time in 114 days in India; Prime Minister Narendra Modi congratulates India’s Oscars win; 16 opposition parties meet to discuss Budget Session strategy;..

Credit: Oneindia Duration: 02:55Published 2 weeks ago

CDC Confirms That Majority of Fatal Covid Vaccines Were Knowingly Sent to Red States [Video]

CDC Confirms That Majority of Fatal Covid Vaccines Were Knowingly Sent to Red States

We published a report last year titled "Evidence that the US government targeted red states with a lethal batch of vaccine," which most outlets ignored because private leaked..

Credit: Rumble Duration: 05:14Published 3 weeks ago

278,000 Americans killed by the vaccine in the first year, notes Peter McCullough, MD [Video]

278,000 Americans killed by the vaccine in the first year, notes Peter McCullough, MD

"278,000 Americans died in the first year of the [COVID-19] vaccine campaign (Dec 2020 - Dec 2021) [according to an analysis by Mark Skidmore (2023) from Michigan State University.]"..

Credit: Rumble Duration: 01:29Published 3 weeks ago